Medicine and Dentistry
Obesity
100%
Semaglutide
100%
Body Mass Index
31%
Adolescent
18%
Lifestyle Intervention
18%
Therapeutic Procedure
12%
Weight Loss
12%
Adverse Event
12%
Amaurosis
6%
Adult
6%
Assessment
6%
Drug
6%
Chemotherapeutic Agent
6%
Age
6%
Incidence
6%
Lipid
6%
Glycated Hemoglobin
6%
Odds Ratio
6%
High Density Lipoprotein Cholesterol
6%
Body Weight
6%
Alanine Aminotransferase
6%
Cholelithiasis
6%
Glucagon-Like Peptide-1 Agonist
6%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Obesity
100%
Semaglutide
100%
Adverse Event
12%
Blindness
6%
Drug
6%
Lipid
6%
Incidence
6%
Glycosylated Hemoglobin
6%
High Density Lipoprotein Cholesterol
6%
Alanine Aminotransferase
6%
Glucagon Like Peptide 1 Receptor Agonist
6%
Cholelithiasis
6%
Neuroscience
Semaglutide
100%
Placebo
50%
Body Mass Index
31%
High Density Lipoprotein Cholesterol
6%
Lipid
6%
Glycosylated Hemoglobin
6%
Alanine Aminotransferase
6%
Glucagon-Like Peptide-1 Receptor Agonist
6%